Sale!
CLSI C43-A2 – Gas Chromatography/Mass Spectrometry Confirmation of Drugs; Approved Guideline-Second Edition, C43A2E
This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid as of September 2016. Because of its value to the laboratory community, it is being retained in CLSI’s library.
This document provides guidance on establishing uniform practices necessary to produce quality data for quantitation and identification of a drug or drug metabolite using the gas chromatography/mass spectrometry method. Specific quality assurance criteria for maintaining and documenting optimal instrument performance are also presented.
Product Details
- Published:
- 03/01/2010
- ISBN(s):
- 1562387200
- File Size:
- 1 file , 2 MB
- Note:
- This product is unavailable in Russia, Belarus
Related products
-
CLSI X06R
$108.00Add to cartProceedings From the QC for the Future Workshop; A Report, X06-R
Published by Publication Date Number of Pages CLSI 06/01/2005 11 -
CLSI VET06
$108.00Add to cartMethods for Antimicrobial Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria Isolated From Animals, 1st Edition, VET06Ed1E
Published by Publication Date Number of Pages CLSI 01/01/2017 114 -
CLSI QMS17
$108.00Add to cartExternal Assessment, Audits, and Inspections of the Laboratory, 1st Edition, QMS17Ed1E
Published by Publication Date Number of Pages CLSI 08/01/2017 94 -
CLSI QMS22
$108.00Add to cartManagement of Paper-based and Electronic Laboratory Information, 1st Edition, QMS22Ed1E
Published by Publication Date Number of Pages CLSI 08/01/2018 78
